Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murat Akova

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
Virulence|March 18, 2016
Epidemiology of antimicrobial resistance in bloodstream infectionsMurat Akova
Infectious Diseases & Clinical Microbiology|April 18, 2024
Infectious Diseases and Clinical Microbiology (IDCM): From Infancy to MaturityMurat Akova
Infectious Diseases & Clinical Microbiology|April 18, 2024
In the Aftermath of a Natural Disaster: The Infectious Diseases may Strike Back…Murat Akova
Idrugs : the Investigational Drugs Journal|June 16, 2004
Clinical microbiology and infectious disease -- 14th European conferenceMurat Akova
Infectious Diseases & Clinical Microbiology|January 2, 2025
Milestones and Momentum: Celebrating Six Years of Progress in <i>Infectious Diseases and Clinical Microbiology</i> (IDCM)Murat Akova
International Journal of Clinical Practice. Supplement|May 17, 2002
Hospital-acquired respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitorsMurat Akova
Infectious Diseases & Clinical Microbiology|March 11, 2026
Toward 2026: Raising the Bar at <i>Infectious Diseases and Clinical Microbiology</i> (IDCM)Murat Akova
Expert Review of Anti-Infective Therapy|March 31, 2025
Febrile neutropenia management in high-risk neutropenic patients: a narrative review on antibiotic prophylaxis and empirical treatmentCemre Boşnak, Murat Akova
Therapeutic Advances in Infectious Disease|August 29, 2014
Management of febrile neutropenia in the era of bacterial resistanceSehnaz Alp, Murat Akova
Trials|April 14, 2021
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trialMurat Akova, Serhat Unal
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Virulence|March 18, 2016
Epidemiology of antimicrobial resistance in bloodstream infectionsMurat Akova
Infectious Diseases & Clinical Microbiology|April 18, 2024
Infectious Diseases and Clinical Microbiology (IDCM): From Infancy to MaturityMurat Akova
Infectious Diseases & Clinical Microbiology|April 18, 2024
In the Aftermath of a Natural Disaster: The Infectious Diseases may Strike Back…Murat Akova
Idrugs : the Investigational Drugs Journal|June 16, 2004
Clinical microbiology and infectious disease -- 14th European conferenceMurat Akova
Infectious Diseases & Clinical Microbiology|January 2, 2025
Milestones and Momentum: Celebrating Six Years of Progress in <i>Infectious Diseases and Clinical Microbiology</i> (IDCM)Murat Akova
International Journal of Clinical Practice. Supplement|May 17, 2002
Hospital-acquired respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitorsMurat Akova
Infectious Diseases & Clinical Microbiology|March 11, 2026
Toward 2026: Raising the Bar at <i>Infectious Diseases and Clinical Microbiology</i> (IDCM)Murat Akova
Expert Review of Anti-Infective Therapy|March 31, 2025
Febrile neutropenia management in high-risk neutropenic patients: a narrative review on antibiotic prophylaxis and empirical treatmentCemre Boşnak, Murat Akova
Therapeutic Advances in Infectious Disease|August 29, 2014
Management of febrile neutropenia in the era of bacterial resistanceSehnaz Alp, Murat Akova
Trials|April 14, 2021
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trialMurat Akova, Serhat Unal
Pageof 18